Article Text
Original research
Two dilemmas for medical ethics in the treatment of gender dysphoria in youth
Abstract
Both the diagnosis and medical treatment of gender dysphoria (GD)—particularly in children and adolescents—have been the subject of significant controversy in recent years. In this paper, we outline the means by which GD is diagnosed in children and adolescents, the currently available treatment options, and the bioethical issues these currently raise. In particular, we argue that the families and healthcare providers of children presenting with GD currently face two main ethical dilemmas in decision making regarding treatment: the pathway dilemma and the consent dilemma.
- ethics
- sexuality/gender
- decision-making
Data availability statement
There are no data in this work.
Statistics from Altmetric.com
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Forever young? The ethics of ongoing puberty suppression for non-binary adults
- Assessment and support of children and adolescents with gender dysphoria
- High court should not restrict access to puberty blockers for minors
- Defending two dilemmas
- Exploring gender dysphoria and related outcomes in a prospective cohort study: protocol for the Swedish Gender Dysphoria Study (SKDS)
- Discharge outcome analysis of 1089 transgender young people referred to paediatric endocrine clinics in England 2008–2021
- Interventions to suppress puberty in adolescents experiencing gender dysphoria or incongruence: a systematic review
- Longitudinal Outcomes of Gender Identity in Children (LOGIC): study protocol for a retrospective analysis of the characteristics and outcomes of children referred to specialist gender services in the UK and the Netherlands
- Flawed reasoning on two dilemmas: a commentary on Baron and Dierckxsens (2021)
- Gender dysphoria in children: puberty blockers study draws further criticism